Cargando…
Effect of lorcaserin on weight reduction in persons with obstructive sleep apnea (OSA): a combined subgroup analysis from three randomized, controlled clinical trials
STUDY OBJECTIVES: To evaluate weight loss with lorcaserin in persons with obstructive sleep apnea (OSA). METHODS: This retrospective analysis evaluated weight loss of lorcaserin (10 mg twice daily) versus placebo in persons with obesity or overweight persons with OSA from a pooled database of three...
Autores principales: | Fujioka, K., Perdomo, C., Malhotra, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587310/ https://www.ncbi.nlm.nih.gov/pubmed/31275597 http://dx.doi.org/10.1002/osp4.340 |
Ejemplares similares
-
Depression and Obstructive Sleep Apnea (OSA)
por: Schröder, Carmen M, et al.
Publicado: (2005) -
Lorcaserin and metabolic disease: weight‐loss dependent and independent effects
por: Bays, H., et al.
Publicado: (2018) -
Pathogenesis of obstructive sleep apnea in individuals with the COPD + OSA Overlap syndrome versus OSA alone
por: Orr, Jeremy E., et al.
Publicado: (2020) -
Sleep Spindle Characteristics in Obstructive Sleep Apnea Syndrome (OSAS)
por: Mohammadi, Hiwa, et al.
Publicado: (2021) -
Obstructive Sleep Apnea Syndrome (OSAS). Review of the literature
por: Azagra-Calero, Eva, et al.
Publicado: (2012)